China says it is ready to promote fair global vaccine distribution. Many countries have already received shipments of Chinese vaccines or signed deals to get them. Mexico signed an agreement to buy 35 million doses of a vaccine from China's CanSino Biologics. In Turkey, h...
As of Dec. 30, everyone except those who have received a third dose of a vaccine will have to present a negative 24-hour test before entering entertainment venues, dance clubs and reception halls for weddings. A medical worker takes a swab from a man for a COVID-19 rapid test in Nicosi...
China has been making contributions to the accessibility and affordability of vaccines in developing countries, although it has a huge population and very tight vaccine supplies itself, said Zhao. He added that China's Sinopharm COVID-19 vaccine has been validated for emergency use by the World ...
Developing countries may face a long wait if they want a vaccine made in the West, but there's always the option of turning to China, an economist from the Development Bank of Singapore said. "Considering the billions of doses needed, and the risk [of] falling at the back of a very ...
GENEVA, March 17 (Xinhua) -- On behalf of over 60 countries, China on Wednesday voiced concern over the inequitable allocation and unbalanced vaccination for COVID-19, saying that the "vaccine divide" is posing the biggest obstacle in defeating the pandemic. ...
The obvious gap between immunity in rich and poorer countries has drawn the attention of many experts. Many have warned that the longer the unequal vaccine distribution exists, the wider COVID-19 spreads, and new variants are more likely to emerge. ...
Amid a COVID surge in Africa, vaccine promises from richer nations are not enough to bring an early end to the pandemic, experts say. By T. V. Padma Twitter Facebook Email Most people in the poorest countries will need to wait another two years before they are vaccinated against COVID-...
As of mid-December, 61.4% of Americans were fully vaccinated against COVID-19 — a rate that disease experts say is inadequate to eradicate the virus. But it’s far better than the shockingly low numbers of some developing countries, where vaccination ra
COVID-19 Vaccine Hesitancy in Eight European Countries: Prevalence, Determinants and Heterogeneitydoi:10.21203/rs.3.rs-840045/v1Janina SteinertHenrike SternbergHannah PrinceGiuseppe Veltri
An important source of COVID-19 vaccine hesitancy that is not yet understood is the availability of various COVID-19 vaccines with different characteristics. Due to the global COVID-19 vaccine shortage, the public in many countries may not be able to choose one vaccine over another. People ma...